Family · Pharmaceutical analytical standards
Capecitabine
An oral chemotherapy drug of the fluoropyrimidine family that is converted in the body into 5-fluorouracil, approved in the United States in 1998 and mainly used in colorectal and breast cancer. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is a 'three-step' prodrug: the final conversion into 5-fluorouracil is carried out by thymidine phosphorylase, an enzyme more abundant in tumour tissue than in healthy tissue.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
